A new analysis has found that the FDA's decisions on the abortion pill were based on science. However, there are conflicting views on the issue, with some outlets suggesting that the pill's safety is being called into question, while others report that the FDA's regulation of the pill has been shaped by evidence and caution. The availability of the abortion pill, mifepristone, by mail has been the subject of recent court actions and congressional scrutiny.